| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M007998200 |
| P698 | PubMed publication ID | 10998425 |
| P2093 | author name string | Moore DD | |
| Dowhan DH | |||
| Urizar NL | |||
| P433 | issue | 50 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 39313-39317 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression | |
| P478 | volume | 275 |
| Q27641086 | A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR |
| Q34304725 | Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice |
| Q28085493 | Bile acid nuclear receptor FXR and digestive system diseases |
| Q26775814 | Bile acid receptors and nonalcoholic fatty liver disease |
| Q36145170 | Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease |
| Q34790389 | Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element |
| Q33610738 | Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration |
| Q33785270 | Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c |
| Q44442896 | Binding mode of 6ECDCA, a potent bile acid agonist of the farnesoid X receptor (FXR). |
| Q34116322 | Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism |
| Q34079471 | Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner. |
| Q35546179 | Effects of FXR in foam-cell formation and atherosclerosis development |
| Q37282312 | FXR: a metabolic regulator and cell protector |
| Q28204827 | Farnesoid X Receptor Regulates Bile Acid-Amino Acid Conjugation |
| Q28191058 | Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression |
| Q28586517 | Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response |
| Q37201353 | Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet |
| Q28591952 | Farnesoid X receptor is essential for normal glucose homeostasis |
| Q24339509 | Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice |
| Q30494062 | Genetic and nongenetic sources of variation in phospholipid transfer protein activity |
| Q35044846 | Genetic background of cholesterol gallstone disease |
| Q37040733 | Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia |
| Q38519853 | Genomic analysis of the response of mouse models to high-fat feeding shows a major role of nuclear receptors in the simultaneous regulation of lipid and inflammatory genes |
| Q44090561 | Guggulsterone: an old approach to a new problem |
| Q42445958 | High-cholesterol diets induce changes in lipid composition of rat erythrocyte membrane including decrease in cholesterol, increase in alpha-tocopherol and changes in fatty acids of phospholipids |
| Q41909885 | Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1. |
| Q44734860 | Ligand-binding domain of farnesoid X receptor (FXR) had the highest sensitivity and activity among FXR variants in a fluorescence-based assay |
| Q37120614 | Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element |
| Q39901207 | Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters |
| Q37970350 | Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target |
| Q38289421 | Nuclear bile acid signaling through the farnesoid X receptor |
| Q34666809 | Nuclear receptor regulation of hepatic function |
| Q35184131 | Nuclear receptors in cholesterol catabolism: molecular biology of the enterohepatic circulation of bile salts and its role in cholesterol homeostasis |
| Q29032141 | On the mechanism of bile acid inhibition of rat sterol 12α-hydroxylase gene (CYP8B1) transcription: roles of α-fetoprotein transcription factor and hepatocyte nuclear factor 4α |
| Q44499489 | PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity |
| Q24623871 | Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR |
| Q60047622 | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome |
| Q34256139 | Proprotein convertases in high-density lipoprotein metabolism |
| Q79236978 | Quantitative Trait Locus Mapping of Genes That Regulate Phospholipid Transfer Activity in SM/J and NZB/BlNJ Inbred Mice |
| Q36763111 | RXR: from partnership to leadership in metabolic regulations |
| Q38293434 | Regulation of HDL genes: transcriptional, posttranscriptional, and posttranslational |
| Q37076509 | Regulation of human class I alcohol dehydrogenases by bile acids |
| Q26738976 | Role of bile acids in the regulation of the metabolic pathways |
| Q35471233 | Role of gut barrier function in the pathogenesis of nonalcoholic Fatty liver disease |
| Q28199120 | The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element |
| Q35057204 | The coming of age of our understanding of the enterohepatic circulation of bile salts |
| Q40102152 | The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes |
| Q41850783 | The nuclear bile acid receptor FXR is activated by PGC-1alpha in a ligand-dependent manner |
| Q34740387 | The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions |
| Q28213571 | The role Acyl-CoA thioesterases play in mediating intracellular lipid metabolism |
| Q34974992 | The role of retinoic acid in hepatic lipid homeostasis defined by genomic binding and transcriptome profiling |
| Q39642788 | Upregulation of scavenger receptor class B type I expression by activation of FXR in hepatocyte |
| Q38323349 | VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium |
| Q36931713 | Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective |
Search more.